Jul 03, 2013

Luitpold Pharmaceuticals, Inc. Provides Adequan® Supply Update

By Luitpold Animal Health - Edited Press Release

Shirley, NY (June 27, 2013) – Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:

Luitpold’s NY facility has undergone significant renovations and upgrades to meet enhanced quality standards and address observations made by the U.S. Food and Drug Administration (FDA). These renovations required cessation of manufacturing and affected Luitpold’s ability to release product. This has resulted in shortages in the marketplace. Luitpold has worked in recent months to optimally allocate inventory and manage the limited remaining supply, which has now been depleted.

Luitpold remains committed to resuming its manufacture and release of Adequan® products. We understand how critically important the Adequan® brands are to the health and well-being of the animals receiving treatment. The company’s latest expectations for reestablishing Adequan® supply to the market is estimated to be first quarter 2014 however, this hinges upon completion of a successful inspection by the FDA.

The company has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.

During this supply interruption, we strongly recommend Veterinarians work together with equine and canine owners and caregivers to evaluate and decide upon the safest and most effective alternative treatments.

Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

Apr 28, 2025 Profile

Lily Dal Cin Found Her People—and Her Purpose—Through Intercollegiate Riding

For Lily Dal Cin, college has been as much about grit and growth as it has been about horses and art. As a member of NC State’s intercollegiate eventing team, she’s weathered setbacks with her horses while continuing to ride, support her teammates, and pursue a demanding degree. Through it all, the team has been her anchor.

Apr 27, 2025 Competitions

fischerChipmunk FRH Carries Jung to His Fifth Defender Kentucky CCI5*-L Title

Even though this is his fifth time winning the CCI5*-L in Kentucky and the 12th five-star win of his career, Michael Jung still thinks luck plays a factor in every competition.

Apr 27, 2025 Competitions

‘He’s More Than Deserving.’ Off The Record and Will Coleman Crowned Cosequin Lexington CCI4*-S Champions at Defender Kentucky

Phillip Dutton couldn’t refrain from laughing as William Coleman described the start of his partnership with the now 16-year-old Irish Sport Horse gelding Off The Record (VDL Arkansas x Drumagoland Bay).

Apr 27, 2025 Competitions

23 to Move Forward to Show Jumping in Defender Kentucky CCI5*-L

It was a somewhat uneventful morning in the final horse inspection for both the Cosequin Lexington CCI4*-S and Defender Kentucky CCI5*-L, which is always a great testament to the exemplary horse care that these top athletes receive and the horsemanship exhibited by their riders.

Official Corporate Sponsors of the USEA

Official Joint Therapy Treatment of the USEA

Official Feed of the USEA

Official Saddle of the USEA

Official Forage of the USEA

Official Competition & Training Apparel of the USEA

Official Horse Boot of the USEA

Official Shock Wave of the USEA

Official Horse Wear of the USEA